Canlyniadau Chwilio - Veronica Teleanu

Mireinio'r Canlyniadau
  1. 1
    Chromothripsis is linked to <i>TP53</i> alteration, cell cycle impairment, and dismal outcome in acute myeloid leukemia with complex karyotype

    Chromothripsis is linked to <i>TP53</i> alteration, cell cycle impairment, and dismal outcome in acute myeloid leukemia with complex karyotype gan Frank G. Rücker, Anna Dolnik, Tamara J. Blätte, Veronica Teleanu, Aurélie Ernst, Felicitas Thol, Michael Heuser, Arnold Ganser, Hartmut Döhner, Konstanze Döhner, Lars Bullinger

    Cyhoeddwyd 2017
    Cael y testun llawn Cael y testun llawn
    Carta
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  2. 2
    Analysis of mutational signatures with yet another package for signature analysis

    Analysis of mutational signatures with yet another package for signature analysis gan Daniel Hübschmann, Lea Jopp‐Saile, Carolin Andresen, Stephen Krämer, Zuguang Gu, Christoph E. Heilig, Simon Kreutzfeldt, Veronica Teleanu, Stefan Fröhling, Roland Eils, Matthias Schlesner

    Cyhoeddwyd 2020
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  3. 3
    A phase I/II study of sunitinib and intensive chemotherapy in patients over 60 years of age with acute myeloid leukaemia and activating <i>FLT3</i> mutations

    A phase I/II study of sunitinib and intensive chemotherapy in patients over 60 years of age with acute myeloid leukaemia and activating <i>FLT3</i> mutations gan Walter Fiedler, Sabine Käyser, Maxim Kebenko, Melanie Janning, Jürgen Krauter, Marcus M. Schittenhelm, Katharina S. Götze, Daniela Weber, Gudrun Göhring, Veronica Teleanu, Felicitas Thol, Michael Heuser, Konstanze Döhner, Arnold Ganser, Hartmut Döhner, Richard F. Schlenk

    Cyhoeddwyd 2015
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  4. 4
    Clonal evolution in relapsed NPM1-mutated acute myeloid leukemia

    Clonal evolution in relapsed NPM1-mutated acute myeloid leukemia gan Jan Krönke, Lars Bullinger, Veronica Teleanu, Florian Tschürtz, Verena I. Gaidzik, Michael W.M. Kühn, Frank G. Rücker, Karlheinz Holzmann, Peter Paschka, Silke Kapp-Schwörer, Daniela Späth, Thomas Kindler, Marcus M. Schittenhelm, Jürgen Krauter, Arnold Ganser, Gudrun Göhring, Brigitte Schlegelberger, Richard F. Schlenk, Hartmut Döhner, Konstanze Döhner

    Cyhoeddwyd 2013
    Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  5. 5
    Monosomal karyotype in adult acute myeloid leukemia: prognostic impact and outcome after different treatment strategies

    Monosomal karyotype in adult acute myeloid leukemia: prognostic impact and outcome after different treatment strategies gan Sabine Käyser, Manuela Zucknick, Konstanze Döhner, Jürgen Krauter, Claus‐Henning Köhne, Heinz A. Horst, Gerhard Held, Marie von Lilienfeld‐Toal, Sibylla Wilhelm, Mathias Rummel, Ulrich Germing, Katharina S. Götze, David Nachbaur, Brigitte Schlegelberger, Gudrun Göhring, Daniela Späth, Carina Morlok, Veronica Teleanu, Arnold Ganser, Hartmut Döhner, Richard F. Schlenk

    Cyhoeddwyd 2011
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  6. 6
    ASXL1 mutations in younger adult patients with acute myeloid leukemia: a study by the German-Austrian Acute Myeloid Leukemia Study Group

    ASXL1 mutations in younger adult patients with acute myeloid leukemia: a study by the German-Austrian Acute Myeloid Leukemia Study Group gan Peter Paschka, R. Schlenk, Verena I. Gaidzik, Julia Herzig, Teresa Aulitzky, Lars Bullinger, Daniela Späth, Veronica Teleanu, Andrea Kündgen, C.-H. Köhne, Peter Brossart, Gerhard Held, Heinz A. Horst, Mark Ringhoffer, Katharina S. Götze, David Nachbaur, Thomas Kindler, Michael Heuser, F. Thol, Arnold Ganser, Hartmut Döhner, Konstanze Döhner

    Cyhoeddwyd 2015
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  7. 7
    TP53 alterations in acute myeloid leukemia with complex karyotype correlate with specific copy number alterations, monosomal karyotype, and dismal outcome

    TP53 alterations in acute myeloid leukemia with complex karyotype correlate with specific copy number alterations, monosomal karyotype, and dismal outcome gan Frank G. Rücker, Richard F. Schlenk, Lars Bullinger, Sabine Käyser, Veronica Teleanu, H. Kett, Marianne Habdank, Carla-Maria Kugler, Karlheinz Holzmann, Verena I. Gaidzik, Peter Paschka, Gerhard Held, Marie von Lilienfeld‐Toal, Michael Lübbert, Stefan Fröhling, Thorsten Zenz, Jürgen Krauter, Brigitte Schlegelberger, Arnold Ganser, Peter Lichter, Konstanze Döhner, Hartmut Döhner

    Cyhoeddwyd 2011
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  8. 8
    Translational and clinical comparison of whole genome and transcriptome to panel sequencing in precision oncology

    Translational and clinical comparison of whole genome and transcriptome to panel sequencing in precision oncology gan Irina Kerle, Thomas Groß, Anja Kögler, Jonathan Arnold, Maximilian Werner, Jan‐Niklas Eckardt, Elena E. Möhrmann, M. Arlt, Barbara Hutter, Jennifer Hüllein, Daniela Richter, Martin Schneider, Mario Hlevnjak, Lino Möhrmann, Dorothea Hanf, Christoph E. Heilig, Simon Kreutzfeldt, Maria‐Veronica Teleanu, Evelin Schröck, Daniel Hübschmann, Peter Horak, Christoph Heining, Stefan Fröhling, Hanno Glimm

    Cyhoeddwyd 2025
    Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  9. 9
    Differential impact of allelic ratio and insertion site in FLT3-ITD–positive AML with respect to allogeneic transplantation

    Differential impact of allelic ratio and insertion site in FLT3-ITD–positive AML with respect to allogeneic transplantation gan Richard F. Schlenk, Sabine Käyser, Lars Bullinger, Guido Kobbe, Jochen Casper, Mark Ringhoffer, Gerhard Held, Peter Brossart, Michael Lübbert, Helmut R. Salih, Thomas Kindler, Heinz A. Horst, Gerald Wulf, David Nachbaur, Katharina S. Götze, Alexander Lamparter, Peter Paschka, Verena I. Gaidzik, Veronica Teleanu, Daniela Späth, Axel Benner, Jürgen Krauter, Arnold Ganser, Hartmut Döhner, Konstanze Döhner

    Cyhoeddwyd 2014
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  10. 10
    Clonal evolution patterns in acute myeloid leukemia with NPM1 mutation

    Clonal evolution patterns in acute myeloid leukemia with NPM1 mutation gan Sibylle Cocciardi, Anna Dolnik, Silke Kapp‐Schwoerer, Frank G. Rücker, Susanne Lux, Tamara J. Blätte, Sabrina Skambraks, Jan Krönke, Florian H. Heidel, Tina M. Schnöder, Andrea Corbacioglu, Verena I. Gaidzik, Peter Paschka, Veronica Teleanu, Gudrun Göhring, Felicitas Thol, Michael Heuser, Arnold Ganser, Daniela Weber, Eric Sträng, Hans A. Kestler, Hartmut Döhner, Lars Bullinger, Konstanze Döhner

    Cyhoeddwyd 2019
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  11. 11
    RUNX1 mutations in acute myeloid leukemia are associated with distinct clinico-pathologic and genetic features

    RUNX1 mutations in acute myeloid leukemia are associated with distinct clinico-pathologic and genetic features gan Verena I. Gaidzik, Veronica Teleanu, Elli Papaemmanuil, Daniela Weber, Peter Paschka, J. Hahn, Till Wallrabenstein, B Kolbinger, C.-H. Köhne, H. -A. Horst, Peter Brossart, Gerhard Held, Andrea Kündgen, Mark Ringhoffer, Katharina S. Götze, Mathias Rummel, Moritz Gerstung, Peter J. Campbell, Johann M. Kraus, Hans A. Kestler, Felicitas Thol, Michael Heuser, Brigitte Schlegelberger, Arnold Ganser, Lars Bullinger, Richard F. Schlenk, Konstanze Döhner, Hartmut Döhner

    Cyhoeddwyd 2016
    Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  12. 12
    Clinical impact of DNMT3A mutations in younger adult patients with acute myeloid leukemia: results of the AML Study Group (AMLSG)

    Clinical impact of DNMT3A mutations in younger adult patients with acute myeloid leukemia: results of the AML Study Group (AMLSG) gan Verena I. Gaidzik, Richard F. Schlenk, Peter Paschka, Anja Stölzle, Daniela Späth, Andrea Kuendgen, Marie von Lilienfeld‐Toal, Wolfram Brugger, Hans Günter Derigs, Stephan Kremers, Richard Greil, Aruna Raghavachar, Mark Ringhoffer, Helmut R. Salih, Mohammed Wattad, Heinz Kirchen, Volker Runde, Gerhard Heil, Andreas Petzer, Michael Girschikofsky, Michael Heuser, Sabine Käyser, Gudrun Goehring, Maria‐Veronica Teleanu, Brigitte Schlegelberger, Arnold Ganser, Jürgen Krauter, Lars Bullinger, Hartmut Döhner, Konstanze Döhner

    Cyhoeddwyd 2013
    Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  13. 13
    Impact of pretreatment characteristics and salvage strategy on outcome in patients with relapsed acute myeloid leukemia

    Impact of pretreatment characteristics and salvage strategy on outcome in patients with relapsed acute myeloid leukemia gan Richard F. Schlenk, Peter Frech, Daniela Weber, Peter Brossart, H-A Horst, Doris Kraemer, Gerhard Held, Mark Ringhoffer, Alexander Burchardt, Guido Kobbe, Katharina S. Götze, David Nachbaur, Thomas Fischer, Michael Lübbert, Helmut R. Salih, Hans Salwender, Gerald Wulf, Elisabeth Koller, Mohammed Wattad, Walter Fiedler, Stephan Kremers, Heinz Kirchen, Bernd Hertenstein, Peter Paschka, Verena I. Gaidzik, Veronica Teleanu, Michael Heuser, Felicitas Thol, Konstanze Döhner, J Krauter, Arnold Ganser, Hartmut Döhner

    Cyhoeddwyd 2017
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  14. 14
    Epidemiological, genetic, and clinical characterization by age of newly diagnosed acute myeloid leukemia based on an academic population-based registry study (AMLSG BiO)

    Epidemiological, genetic, and clinical characterization by age of newly diagnosed acute myeloid leukemia based on an academic population-based registry study (AMLSG BiO) gan Gabriele Nagel, Daniela Weber, Ella Fromm, Sophie Erhardt, Michael Lübbert, Walter Fiedler, Thomas Kindler, J. Krauter, Peter Brossart, Andrea Kündgen, Helmut R. Salih, Jörg Westermann, Gerald Wulf, Bernd Hertenstein, Mohammed Wattad, Katharina S. Götze, Doris Kraemer, Thomas Heinicke, Michael Girschikofsky, Hans-Günter Derigs, Heinz A. Horst, Christiane Rudolph, Michael Heuser, Gudrun Göhring, Veronica Teleanu, Lars Bullinger, Felicitas Thol, Verena I. Gaidzik, Peter Paschka, Konstanze Döhner, Arnold Ganser, Hartmut Döhner, Richard F. Schlenk

    Cyhoeddwyd 2017
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  15. 15
    NCT/DKFZ MASTER handbook of interpreting whole-genome, transcriptome, and methylome data for precision oncology

    NCT/DKFZ MASTER handbook of interpreting whole-genome, transcriptome, and methylome data for precision oncology gan Andreas Möck, Maria‐Veronica Teleanu, Simon Kreutzfeldt, Christoph E. Heilig, Jennifer Hüllein, Lino Möhrmann, Arne Jahn, Dorothea Hanf, Irina Kerle, Hans Martin Singh, Barbara Hutter, Sebastian Uhrig, Martina Fröhlich, Olaf Neumann, Andreas Hartig, Sascha Brückmann, Steffen Hirsch, Kerstin Grund, Nicola Dikow, Daniel B. Lipka, Marcus Renner, Irfan Ahmed Bhatti, Leonidas Apostolidis, Richard F. Schlenk, Christian P. Schaaf, Albrecht Stenzinger, Evelin Schröck, Daniel Hübschmann, Christoph Heining, Peter Horak, Hanno Glimm, Stefan Fröhling

    Cyhoeddwyd 2023
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  16. 16
    Impact of gemtuzumab ozogamicin on MRD and relapse risk in patients with <i>NPM1</i>-mutated AML: results from the AMLSG 09-09 trial

    Impact of gemtuzumab ozogamicin on MRD and relapse risk in patients with <i>NPM1</i>-mutated AML: results from the AMLSG 09-09 trial gan Silke Kapp‐Schwoerer, Daniela Weber, Andrea Corbacioglu, Verena I. Gaidzik, Peter Paschka, Jan Krönke, Frauke Theis, Frank G. Rücker, Maria‐Veronica Teleanu, Ekaterina Panina, Nikolaus Jahn, Julia Herzig, Lena Kubanek, Anika Schrade, Gudrun Göhring, Walter Fiedler, Thomas Kindler, Thomas Schroeder, Karin Mayer, Michael Lübbert, Mohammed Wattad, Katharina S. Götze, Heinz A. Horst, Elisabeth Koller, Gerald Wulf, Jan Schleicher, Martin Bentz, Jürgen Krauter, Lars Bullinger, Julia Krzykalla, Axel Benner, Richard F. Schlenk, Felicitas Thol, Michael Heuser, Arnold Ganser, Hartmut Döhner, Konstanze Döhner

    Cyhoeddwyd 2020
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  17. 17
    Comprehensive genomic and epigenomic analysis in cancer of unknown primary guides molecularly-informed therapies despite heterogeneity

    Comprehensive genomic and epigenomic analysis in cancer of unknown primary guides molecularly-informed therapies despite heterogeneity gan Lino Möhrmann, Maximilian Werner, Małgorzata Oleś, Andreas Möck, Sebastian Uhrig, Arne Jahn, Simon Kreutzfeldt, Martina Fröhlich, Barbara Hutter, Nagarajan Paramasivam, Daniela Richter, Katja Beck, Ulrike Winter, Katrin Pfütze, Christoph E. Heilig, Veronica Teleanu, Daniel B. Lipka, Marc Zapatka, Dorothea Hanf, Catrin List, Michael Allgäuer, Roland Penzel, Gina Rüter, Ivan Jelas, Rainer Hamacher, Johanna Falkenhorst, Sebastian Wagner, Christian Brandts, Melanie Boerries, Anna Lena Illert, Klaus H. Metzeler, C. Benedikt Westphalen, Alexander Desuki, Thomas Kindler, Gunnar Folprecht, Wilko Weichert, Benedikt Brors, Albrecht Stenzinger, Evelin Schröck, Daniel Hübschmann, Peter Horak, Christoph Heining, Stefan Fröhling, Hanno Glimm

    Cyhoeddwyd 2022
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  18. 18
    Genomic landscape and molecularly informed therapy in thymic carcinoma and other advanced thymic epithelial tumors

    Genomic landscape and molecularly informed therapy in thymic carcinoma and other advanced thymic epithelial tumors gan Lino Möhrmann, Lysann Rostock, Maximilian Werner, Małgorzata Oleś, Jonathan Arnold, Nagarajan Paramasivam, Korinna Jöhrens, Luise Rupp, Marc Schmitz, Daniela Richter, Sebastian Uhrig, Martina Fröhlich, Barbara Hutter, Jennifer Hüllein, Arne Jahn, M. Arlt, Elena E. Möhrmann, Dorothea Hanf, Laura Gieldon, Simon Kreutzfeldt, Christoph E. Heilig, Maria‐Veronica Teleanu, Daniel B. Lipka, Katja Beck, Annika Baude-Müller, Andreas Möck, Ivan Jelas, Damian Rieke, Marcel Wiesweg, Christian Brandts, Melanie Boerries, Anna Lena Illert, Alexander Desuki, Thomas Kindler, Angela M. Krackhardt, C. Benedikt Westphalen, Petros Christopoulos, Leonidas Apostolidis, Albrecht Stenzinger, Michael Allgäuer, Olaf Neumann, Irina Kerle, Peter Horak, Christoph Heining, Heidrun Grosch, Evelin Schröck, Daniel Hübschmann, Stefan Fröhling, Hanno Glimm

    Cyhoeddwyd 2025
    Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  19. 19
    Comprehensive Genomic and Transcriptomic Analysis for Guiding Therapeutic Decisions in Patients with Rare Cancers

    Comprehensive Genomic and Transcriptomic Analysis for Guiding Therapeutic Decisions in Patients with Rare Cancers gan Peter Horak, Christoph Heining, Simon Kreutzfeldt, Barbara Hutter, Andreas Möck, Jennifer Hüllein, Martina Fröhlich, Sebastian Uhrig, Arne Jahn, Andreas Rump, Laura Gieldon, Lino Möhrmann, Dorothea Hanf, Veronica Teleanu, Christoph E. Heilig, Daniel B. Lipka, Michael Allgäuer, Leo Ruhnke, Andreas Laßmann, Volker Endris, Olaf Neumann, Roland Penzel, Katja Beck, Daniela Richter, Ulrike Winter, Stephan Wolf, Katrin Pfütze, Christina Geörg, Bettina Meißburger, Ivo Buchhalter, Marinela Augustin, Walter E. Aulitzky, Peter Hohenberger, Matthias Kroiß, Peter Schirmacher, Richard F. Schlenk, Ulrich Keilholz, Frederick Klauschen, Gunnar Folprecht, Sebastian Bauer, Jens T. Siveke, Christian Brandts, Thomas Kindler, Melanie Boerries, Anna Lena Illert, Nikolas von Bubnoff, Philipp J. Jost, Karsten Spiekermann, Michael Bitzer, Klaus Schulze‐Osthoff, Christof von Kalle, Barbara Klink, Benedikt Brors, Albrecht Stenzinger, Evelin Schröck, Daniel Hübschmann, Wilko Weichert, Hanno Glimm, Stefan Fröhling

    Cyhoeddwyd 2021
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  20. 20
    Comprehensive cancer predisposition testing within the prospective MASTER trial identifies hereditary cancer patients and supports treatment decisions for rare cancers

    Comprehensive cancer predisposition testing within the prospective MASTER trial identifies hereditary cancer patients and supports treatment decisions for rare cancers gan Arne Jahn, Andreas Rump, Thomas J. Widmann, Christoph Heining, Peter Horak, Barbara Hutter, Nagarajan Paramasivam, Sebastian Uhrig, Laura Gieldon, S. Drukewitz, A. Kübler, Marion Bermudez, Karl Hackmann, Joseph Porrmann, Johannes Maximilian Wagner, M. Arlt, Martin Franke, Jan A. Fischer, Zarah Kowalzyk, Doreen William, V. Weth, S. Oster, Martina Fröhlich, Jennifer Hüllein, Corina Gonzalez, Simon Kreutzfeldt, Andreas Möck, Christoph E. Heilig, Daniel B. Lipka, Lino Möhrmann, Dorothea Hanf, Małgorzata Oleś, Veronica Teleanu, Michael Allgäuer, Leo Ruhnke, Oliver Kutz, Alexander Knurr, Andreas Laßmann, Volker Endris, Olaf Neumann, Roland Penzel, Kristina Beck, Daniela Richter, Ulrike Winter, Stephan Wolf, Katrin Pfütze, Christina Geörg, Bettina Meißburger, Ivo Buchhalter, Marinela Augustin, Walter E. Aulitzky, Peter Hohenberger, Matthias Kroiß, Peter Schirmacher, Richard F. Schlenk, Ulrich Keilholz, Frederick Klauschen, Gunnar Folprecht, Sebastian Bauer, Jens T. Siveke, Christian Brandts, Thomas Kindler, Melanie Boerries, Anna Lena Illert, Nikolas von Bubnoff, Philipp J. Jost, Klaus H. Metzeler, Michael Bitzer, Klaus Schulze‐Osthoff, Christof von Kalle, Benedikt Brors, Albrecht Stenzinger, Wilko Weichert, Daniel Hübschmann, Stefan Fröhling, Hanno Glimm, Evelin Schröck, Barbara Klink

    Cyhoeddwyd 2022
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:

Offerynnau Chwilio: